Search results for " screening"

showing 10 items of 898 documents

Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies

2012

Background— Genetic determinants of peripheral arterial disease (PAD) remain largely unknown. To identify genetic variants associated with the ankle-brachial index (ABI), a noninvasive measure of PAD, we conducted a meta-analysis of genome-wide association study data from 21 population-based cohorts. Methods and Results— Continuous ABI and PAD (ABI ≤0.9) phenotypes adjusted for age and sex were examined. Each study conducted genotyping and imputed data to the ≈2.5 million single nucleotide polymorphisms (SNPs) in HapMap. Linear and logistic regression models were used to test each SNP for association with ABI and PAD using additive genetic models. Study-specific data were combined using fi…

Malegenetic associationGenome-wide association studyAetiology screening and detection [ONCOL 5]030204 cardiovascular system & hematologyBioinformaticsCohort Studies0302 clinical medicineRisk FactorsGenotypeCARDIOVASCULAR RISK-FACTORSInternational HapMap ProjectGenetics (clinical)POPULATIONGeneticsAged 80 and overPeripheral Vascular Diseases0303 health scienceseducation.field_of_studyAge FactorsMiddle AgedPhenotypeperipheral vascular diseaseMeta-analysiscardiovascular system/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingCORONARY-ARTERY-DISEASEFemaleCardiology and Cardiovascular MedicineChromosomes Human Pair 9AdultSUSCEPTIBILITY LOCIGenotypePopulationHapMap ProjectBiologyPolymorphism Single NucleotideArticleMolecular epidemiology [NCEBP 1]03 medical and health sciencesSex FactorsSDG 3 - Good Health and Well-beingGeneticscohort studyHumansAnkle Brachial Indexcardiovascular diseasesAlleleeducationHealth aging / healthy living Cardiovascular diseases [IGMD 5]AllelesMolecular epidemiology Aetiology screening and detection [NCEBP 1]030304 developmental biologyGenetic associationAgedCyclin-Dependent Kinase Inhibitor p15ABDOMINAL AORTIC-ANEURYSMcohort study ; genetic association ; genome-wide association study ; meta-analysis ; peripheral vascular diseasegenome-wide association studyMORTALITYChromosomeGENEmeta-analysisbody regionsLogistic ModelsMYOCARDIAL-INFARCTIONATHEROSCLEROSISSEQUENCE VARIANThuman activities
researchProduct

Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohort

2020

 In order to reduce alcohol relapse after liver transplantation (LT), the German national guidelines for waiting-list maintenance and organ allocation demand a minimum 6-month period of alcohol abstinence pre-LT, confirmed by measuring urinary ethyl glucuronide (uEtG). Between January 2015 and June 2016, uEtG was measured at least once in 339 cirrhotic patients with an indication for LT at the University Medical Center Mainz. uEtG was measured with an enzyme-linked immunosorbent assay (ELISA) screening test (cutoff value: 500 µg/L). For uEtG values ≥ 500 µg/L, liquid chromatography-mass spectrometry (LC-MS/MS) was performed as a confirmatory assay. Data were collected prospectively in a tra…

Malemedicine.medical_specialtyAlcohol DrinkingWaiting ListsUrinary systemmedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayGlucuronatesLiver transplantationSensitivity and SpecificityGastroenterologyCohort Studies03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEthyl glucuronideLiver Cirrhosis AlcoholicPredictive Value of TestsTandem Mass SpectrometryInternal medicineHumansMass ScreeningMedicineProspective Studies030212 general & internal medicineProspective cohort studyMean corpuscular volumeAgedCreatinineEthanolmedicine.diagnostic_testbusiness.industryGastroenterologyMiddle AgedLiver TransplantationchemistryPredictive value of testsFemale030211 gastroenterology & hepatologybusinessBiomarkersChromatography LiquidAlcohol AbstinenceZeitschrift für Gastroenterologie
researchProduct

Need for global action for cancer control.

2008

Malemedicine.medical_specialtyCancer ResearchInternational CooperationUterine cervix cancerDiseaseGlobal HealthWorld health03 medical and health sciences0302 clinical medicineCancer controlSDG 3 - Good Health and Well-beingNeoplasmsCancer screeningmedicineGlobal healthHumans030212 general & internal medicineGynecologyHealth Services Needs and DemandCancer preventionbusiness.industryHematologyPrimary Prevention/dk/atira/pure/subjectarea/asjc/2700/2730Risk analysis (engineering)Action (philosophy)Oncology030220 oncology & carcinogenesisFemalebusiness/dk/atira/pure/subjectarea/asjc/1300/1306Annals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Trends in Frequency and Management of Obstructing Colorectal Cancers in a Well-Defined Population

2007

Few population-based studies investigate obstructing colorectal cancers. This study was designed to describe trends in their frequency and management. Data were obtained for 13,331 colorectal cancers registered by the population-based cancer registry of Burgundy, France, between the years 1976 and 2000. Obstructing cancers represented 8.3 percent of all colorectal cancers. This proportion was stable throughout the study. Resection for cure increased from 54.9 percent (1976–1980) to 71.4 percent (1996–2000; P = 0.011). Using multivariate analysis, site of cancer and period of diagnosis were the only factors significantly associated to a curative resection. Postoperative mortality for obstruc…

Malemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterologySurgical oncologyInternal medicineHumansMedicineHospital MortalityRegistrieseducationMass screeningAgedNeoplasm StagingAged 80 and overeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Age FactorsGastroenterologyCancerGeneral MedicineMiddle Agedmedicine.diseaseColorectal surgeryCancer registryFemaleFranceColorectal NeoplasmsbusinessIntestinal ObstructionDiseases of the Colon & Rectum
researchProduct

Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer

2014

Abstract Background Several randomized trials have shown a reduction of colorectal cancer mortality by screening using guaiac-based faecal occult blood tests. However, little is known on the long-term effect of screening at the population level in everyday practice. Methods Small-sized geographic areas including a total of 91,199 individuals were allocated to either biennal screening using the Hemoccult-II test or no screening. The expected mortality and incidence in the cohort invited to screening was determined using mortality and incidence in the non-screened population. Results Colorectal cancer mortality was significantly lower in the population invited to screening than in the non-scr…

Malemedicine.medical_specialtyColorectal cancerPopulationlaw.inventionRandomized controlled triallawInternal medicinemedicineHumansMass ScreeningTerm effecteducationEarly Detection of CancerMass screeningAgedGynecologyeducation.field_of_studyHepatologybusiness.industryIncidenceIncidence (epidemiology)GastroenterologyMiddle Agedmedicine.diseaseStandardized mortality ratioOccult BloodCohortFemaleFranceColorectal NeoplasmsbusinessFollow-Up StudiesDigestive and Liver Disease
researchProduct

Delay in the Diagnosis of Breast and Colorectal Cancer in People With Severe Mental Disorders

2020

Background People with severe mental disorders have a worse cancer prognosis, with higher mortality rates than the general population, and this could be partially attributed to a later detection. Breast cancer and colorectal cancer have mass population screenings in Spain, but the influence in early diagnosis is unknown in persons with severe mental disorders. Objective To compare the severity of breast and colorectal cancers at diagnosis in people with and without mental disorders. Methods This was an observational, retrospective, case-control study with 1:2 matching performed in Eastern Spain. Data were retrieved for analysis from electronic medical records. Results The study included 111…

Malemedicine.medical_specialtyDelayed DiagnosisColorectal cancerPopulationBreast NeoplasmsMental disordersColorectal neoplasms03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineCancer screeningOdds RatioHumansMedicineeducationEarly Detection of CancerAgedRetrospective Studieseducation.field_of_study030504 nursingOncology (nursing)business.industryMental DisordersRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseMental healthOncologySpainCase-Control StudiesEarly detection of cancer030220 oncology & carcinogenesisRelative riskNeoplasm stagingFemaleBreast neoplasmsColorectal Neoplasms0305 other medical sciencebusinessCancer Nursing
researchProduct

Epidemiology, prevention and screening for prostate cancer.

1996

Prostate cancer is a growing social problem. The economical impact is high and is likely to become greater in future years, not only because the number of patients diagnosed with prostatic neoplasias is increasing steadily, but also because of the promotion of screening programmes and the rise in the number of surgical procedures available. It can be concluded that, at the present stage, widespread implementation of screening cannot be recommended. The answer to the question of screening can only be provided by large randomised trials, comparing either screening versus no screening, or early versus delayed treatment in patients in whom early cancer is detected by screening.

Malemedicine.medical_specialtyEarly cancerUrologyCost-Benefit AnalysisRisk AssessmentProstate cancerEpidemiologymedicineHumansMass ScreeningIn patientStage (cooking)Intensive care medicineRandomized Controlled Trials as TopicPalpationbusiness.industryRectumProstatic NeoplasmsDelayed treatmentSurgical proceduresMiddle AgedProstate-Specific Antigenmedicine.diseasePrimary PreventionPhysical therapybusinessEuropean urology
researchProduct

Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia.

2020

Background and Aims: Studies suggest that the prevalence of celiac disease (CD) is increased in individuals with functional gastrointestinal disorders (FGIDs), in particular, irritable bowel syndrome (IBS); however, the evidence is conflicting. We aimed to analyze the prevalence of CD in patients with FGIDs in Latvia.
 Methods: This retrospective study included patients with FGIDs, referred for a gastroenterologist consultation in a secondary gastroenterology practice unit. Patients were divided into three groups – patients only with IBS (IBS group), patients only with functional dyspepsia (FD) (FD group), patients with mixed symptoms IBS and FD (Mixed group). Patient levels of tissue …

Malemedicine.medical_specialtyGastrointestinal DiseasesDiseaseGastroenterologySerologyIrritable Bowel SyndromeGTP-Binding ProteinsInternal medicineBiopsymedicinePrevalenceHumansMixed groupIn patientProtein Glutamine gamma Glutamyltransferase 2Serologic TestsDuodenoscopyIrritable bowel syndromeAutoantibodiesRetrospective StudiesRoutine screeningTransglutaminasesmedicine.diagnostic_testbusiness.industryGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseaseLatviaImmunoglobulin ACeliac DiseaseFemaleSymptom AssessmentbusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?

2020

Background and Aims: Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations.
 Methods: A total of 3,455 questionnaires from the pilot study of the “Helicobacter pylori eradication and pepsinogen testing for…

Malemedicine.medical_specialtyHealth BehaviorColonoscopyPilot ProjectsLogistic regressionHelicobacter InfectionsScreening programmeRisk FactorsInternal medicineSurveys and QuestionnairesCancer screeningmedicineHumanscardiovascular diseasesFamily historyMedical History TakingEarly Detection of CancerGastrointestinal Neoplasmsbiologymedicine.diagnostic_testHelicobacter pyloribusiness.industryGastroenterologyCancerFaecal occult bloodColonoscopyHelicobacter pyloriPatient Acceptance of Health Caremedicine.diseasebiology.organism_classificationLatviaSocioeconomic FactorsFemalebusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Immunochemical faecal occult blood tests for colorectal cancer screening: No time to lose

2013

Malemedicine.medical_specialtyHepatologybusiness.industryImmunochemistryGastroenterologyFaecal occult bloodGastroenterologyColorectal cancer screeningOccult BloodInternal medicineImmunochemistryHumansMedicineFemaleColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct